The Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
Smarter leaders trust GlobalData
The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Infectious Disease which include the indications Melanoma, Metastatic Colorectal Cancer, Lung Disease, Acute Respiratory Failure, Skin Ulcers, Wounds, Respiratory Syncytial Virus (RSV) Infections, and Mycobacterium Infections. It also reviews key players involved in Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha targeted therapeutics development with respective active and dormant or discontinued products.
The Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha pipeline targets constitutes close to 17 molecules. Out of which, approximately 15 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, and Preclinical stages are 1, 1, 8, and 5 respectively. Similarly, the universities portfolio in Phase II, and Preclinical comprises 1, and 1 molecule.
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha overview
Granulocyte macrophage colony stimulating factor receptor subunit alpha also known as CD116 is a receptor for granulocyte macrophage colony-stimulating factor. It is a member of the cytokine family of receptors. It plays an important role in controls the production, differentiation, and function of granulocytes and macrophages.
For a complete picture of Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third-party sources.
Drug profiles featured in the report undergo periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
